Skip to content
GenoLensGenoLens

MAP1B

Chr 5q13.2

microtubule associated protein 1B

Aliases:
MAP5, PPP1R102
MANE:
ENST00000296755.12

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Intellectual disability

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Malformations of cortical development

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Fetal anomalies

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Hereditary neuropathy

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • periventricular nodular heterotopia 9

    0.76
  • hearing loss, autosomal dominant 83

    0.55
  • neurodegenerative disease

    0.54
  • periventricular nodular heterotopia

    0.52
  • hereditary disease

    0.50
  • autosomal dominant nonsyndromic hearing loss

    0.37
  • chromosome 5Q14.3 deletion syndrome, distal

    0.34
  • attention deficit-hyperactivity disorder

    0.34
  • Global developmental delay

    0.33
  • liver cancer

    0.33

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Microtubule-associated protein 1B

Facilitates tyrosination of alpha-tubulin in neuronal microtubules (By similarity). Phosphorylated MAP1B is required for proper microtubule dynamics and plays a role in the cytoskeletal changes that accompany neuronal differentiation and neurite extension (PubMed:33268592). Possibly MAP1B binds to at least two tubulin subunits in the polymer, and this bridging of subunits might be involved in nucleating microtubule polymerization and in stabilizing microtubules. Acts as a positive cofactor in DAPK1-mediated autophagic vesicle formation and membrane blebbing

Curated MONDO disease pages that list MAP1B among their top associated genes.

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.